Lv11
98 积分 2025-06-06 加入
Intra-channel bi-epitopic crosslinking unleashes ultrapotent antibodies targeting NaV1.7 for pain alleviation
8小时前
待确认
A robust heterodimeric Fc platform engineered for efficient development of bispecific antibodies of multiple formats
8小时前
已完结
Development of an allosteric adhesion GPCR nanobody with therapeutic potential
12天前
已完结
Rapidly accelerated development of neutralizing COVID‐19 antibodies by reducing cell line and CMC development timelines
2个月前
已完结
A high‐fidelity, dual site‐specific integration system in CHO cells by a Bxb1 recombinase
2个月前
已完结
HER2-XPAT, a novel protease-activatable pro-drug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP)
3个月前
已关闭
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase
4个月前
已完结
皖公网安备34019202002308
